Intrinsic Value

PSYBF doesn't have a meaningful market cap.
Not Available for PSYBF

There is not enough data to reliably calculate the intrinsic value for Psybio Therapeutics Corp.

Do our valuations actually work? See backtest results .

Alternatives to PSYBF

Fundamental Analysis

What Psybio Therapeutics Does

PsyBio Therapeutics Corp. engages in the development of drugs intended for the treatment of mental health challenges and other disorders. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2011-02-08. The firm is developing a new class of drugs intended for the treatment of mental health challenges and other disorders. The firm is in the process of developing its portfolio of product candidates for sale in the pharmaceutical industry.

Headquarters
Canada CA
IPO date
Feb 8, 2011
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Psybio Therapeutics Corp

Wall St Price Targets

Capital Returns

Buyback Yield
LOCKED
Debt Paydown Yield
LOCKED

Competitive Landscape